Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FDA authorizes Bayer contraceptive for new indication
The approval makes Yaz the first and only oral contraceptive approved by the FDA for three distinct indications. Yaz has received approval as an oral contraceptive and as
The approval makes Yaz the first and only oral contraceptive approved by the FDA for three distinct indications. Yaz has received approval as an oral contraceptive and as
The drug, T-0047, was placed on clinical hold by the FDA in response to the reports that progressive multifocal leukoencephalopathy (PML), a rare nerve disorder, was associated with
China is currently experiencing rapid economic growth, which is driving even higher growth rates for healthcare expenditure. Commenting on the announcement, Richard Baker, Alliance Boots chief executive, said:
According to Roche, Tarceva is the first treatment in over a decade to have shown a significant survival benefit in treating patients with this disease. The approval follows
There was a strong turnout at the meeting, Icos reported, where 77% of the shares voted were cast in support of the merger. Eli Lilly previously increased its
The trial was examining patients who had cancer but were not receiving chemotherapy or radiation. The trial was designed to see whether Aranesp would be useful for patients
Copegus is an antiviral agent developed by F Hoffmann-La Roche for use in combination with Pegasys for treating chronic hepatitis C. After Copegus was filed in June 2005,
GenVec is sponsoring two separate phase I/II studies at the University of Chicago to explore the use of TNFerade as a second-line treatment for unresectable, recurrent tumors, and
The vaccine is developed using Crucell’s PER.C6 technology, a cell line developed for the large-scale manufacture of biopharmaceutical products, including vaccines. Three different dosages of the vaccine were
A commitment to complete post-marketing trials has become a condition of approval for many drugs and this trial was expected to take three to four years to complete.